Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.1150 (-2.18%) ($12.1150 - $12.1150) on Thu. Apr. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.04% (three month average) | RSI | 70 | Latest Price | $12.1150(-2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 9.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.52% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-1%) TLT(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.52% (StdDev 7.04%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $12.29(-1.42%) | 10 Day Moving Average | $11.92(1.64%) | 20 Day Moving Average | $11.1(9.14%) | To recent high | -11.1% | To recent low | 40.9% | Market Cap | $2.137b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |